Derivatives of 2-((4-piperidinyl)methyl)-1,2,3,4-tetrahydroisoquinoline, their preparation and their application in therapeutics
US4925850A · kind A · utility
6Cited by
5References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1989 |
| Grant date | May 15, 1990 |
| Priority date | — |
| Expiry date | Feb 6, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I): ##STR1## in which: X is hydrogen or a methyl or methoxy group; PA0 Y is a halogen or a methyl or methoxy group; and PA0 R is a group of formula --Z--R' in which: PA0 Z is a --CH.sub.2 -- group, and PA0 R' is a phenyl group unsubstituted or substituted by one, two or three substituents selected from halogen atoms and trifluoromethyl, linear or branched (C.sub.1 -C.sub.3) alkyl and linear or branched (C.sub.1 -C.sub.3) alkoxy groups; or a pharmacologically acceptable acid addition salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.